Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
VABIO E-News August 28, 2014
Share |
Email not looking beautiful? View it in your browser



Become a Member



VABIO E-News: August 28, 2014 Edition

Focus Around Virginia
A Word from CEO Jeff Gallagher

Members and friends of Virginia Bio,

It is a key part of our mission and a true joy at Virginia Bio to gather, shape and tell the powerful story of the bioscience community in Virginia. One aspect, frequently underappreciated, is the rich and diverse offerings our members mount to educate and connect Virginians with one another and the world.

We are honored and excited to promote our members’ significant events among our membership and our followers, and we regularly do so on our website. Please take a moment to familiarize yourself with our Community Calendar. Attend some of these great events as well as our Virginia Bio events, learn, benefit, contribute and help us further develop the bioscience community in the Commonwealth.

Here’s a snapshot taken today of some of the significant events planned by members across the state over the next eight weeks with national and international profile and scope. Not to mention, our many Virginia Bio events. More details and appropriate member site links are on our Community Calendar.


For complete article click here.


Thank you to our Premium Partners

Chairman's Circle:
tt

PLATINUM PARTNERS
:


Gold Partners:


tt tt
Silver Partners:

Virginia Tech Fralin Life Science Institute VWR

In this issue
focus around Virginia
VABIO Articles
VABIO Community News
VABIO Anniversaries
VABIO Calendar

VABIO News
2 VA CEO's Make 2014 PharmaVOICE 100 List
CADENCE CONTINUES GROWTH
MicroVAX Cancer Vaccine - Human Trial
Intrexon Enters Bovine Genetics
CIT GAP Funds Invests in PhosImmune
HemoSonic Names new leadership
'BEER AND BIOTEACH' TO EDUCATE TEACHERS
VT REVOLUTIONIZES BRAIN CANCER DIAGNOSIS
AlBioTech & ledos USAF Contract
NEW OFFERING FOR VIRGINIA BIO MEMBERS
OWENS & MINOR SUCCESSION PLAN
OXFORD FINANCE CLOSES DEBT FACILITY

Welcome DATA BLUEPRINT

Welcome FINNEGAN
WELCOME KLICK HEALTH
WELCOME SENSEI LABS
WELCOME THERMO FISHER
VABIO COMMUNITY NEWS

VABIO Member Anniversaries

VABIO Events
Virginia Bio Calendar





VABIO Articles TO TOP

VA CEO's Make the 2014 PharmaVOICE 100 List

Established 10 years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry.

Two such individuals named to this prestigious and very selective list include CEOs from Health Diagnostic Labs, Tonya Mallory, and HemoShear, James Powers. These executives illustrate what it means to think bigger, do more, and lead with passion and integrity.

For complete article click here.

New Acquisitions and Record Revenue In 2014 For Cadence

Cadence, Inc., a contract manufacturer of components for medical devices, acquired three operating business units of Plainfield Precision Holdings, located in Sturgeon Bay, WI, Plymouth, MA and Santo Domingo, Dominican Republic.

For complete article click here.

Additionally, they announced unaudited revenue results of $33.6 million for the first six months of 2014, a 26% increase in revenue compared to 2013. Net income and earnings per share increased 48% over prior year to $1.49 per share. Earnings before interest, taxes, depreciation and amortization (EBITDA) were up 22% to $6.8 million.

For complete article click here.



MicroVAX Cancer Vaccine First in Human Clinical Trial in Singapore

MicroVAX, LLC, a clinical stage biotech company located in Prince William County, began a phase I clinical trial for its unique and proprietary vaccine platform that allows under the provisions of an FDA IND entry of patients with cancers of the breast, prostate, colon, ovary and lung, that have relapsed after initial salvage therapy. When fully implemented, the MicroVAX vaccine is designed to both destroy pre-existing cancerous tumors and prevent cancer.

Jake Frank, managing member of MicroVAX said, "MicroVAX is delighted to be partnering with Dr. Toh Han Chong and his world class team of clinical cancer immunologists from the National Cancer Center Singapore, and the Singapore Clinical Research Institute on the initial clinical testing of its cancer vaccine."

For complete article click here.

Intrexon Launches Leadership Platform in Bovine Genetics

Intrexon Corporation (NYSE: XON), has completed the acquisition of Trans Ova Genetics, L.C., a provider of bovine reproductive technologies. Trans Ova, as a wholly owned subsidiary of Intrexon, will operate under the leadership of David Faber, D.V.M., President, and his management team.

"With continued expansion of the world's population, the present approaches to produce food and protein are in need of transformational reproductive technologies to drive a sustainable path forward for current and future generations," said Dr. Faber. "The combined capabilities and expertise of Intrexon and Trans Ova supply the means to enhance the rate of genetic progress globally, providing cattle farmers superior productivity and efficient utilization of resources in an environmentally responsible manner."

For complete article click here.

CIT GAP Funds Invests in PhosImmune

The Center for Innovative Technology (CIT) closed an investment in PhosImmune, a Charlottesville-based clinical-stage biotechnology company developing therapeutic cancer vaccines.

PhosImmune controls a library of unique, aberrantly phosphorylated tumor antigens (PTAs) that are directly implicated in metastasis. The company's lead PTA candidate, PxM-01, stemmed from research at the University of Virginia and is currently in Phase I testing to treat melanoma.

For complete article click here.


New HemoSonic Chairman Pleased About New President/CEO

HemoSonics, a medical device company developing a novel point-of-care diagnostic to measure coagulation, named William P. (Bill) Moffitt as the new Chairman of the Board of Managers and appointed Timothy J. Fischer as President and Chief Executive Officer.

Moffitt has 40 years of experience in the medical device and diagnostic industries and has spent the last 25 years developing novel technologies into products and solutions that have helped shape the industry.

"Bill brings a wealth of practical experience in building companies and commercializing revolutionary in vitro diagnostics,” said William F. Walker, Founder and CTO of HemoSonics. "We are thrilled to have him as part of the team.”

For complete article click here.

Support 'Beer and Biotech' events to Educate Teachers

During Virginia's first ever Science Festival Week, October 4-11, a number of family-oriented activities have been planned to celebrate the sciences across Commonwealth. The Virginia Bio Foundation, the 501c(3) charitable subsidiary of Virginia Bio is playing a big part in the celebration by coordinating 'Beer and Biotech' events' for teachers.

Virginia Bio has obtained the enthusiastic participation of several member companies in regions across Virginia to open their doors to teachers from grades K through 12. The events are planned on Thursday, October 9, from 4:30 – 6:30. "Beer and BioTeach" will host local teachers for cocktails, snacks and discussion about what each business does along with tours of the labs. Participating companies include: Engineered Biopharmaceuticals, LifeNet Health, VA Dept. of Consolidate Laboratories, TECHLAB, Novozymes and HemoShear. We are seeking additional bioscience companies in other areas, and funding. If you're organization would like to participate, please contact us.

For complete article click here.

VT Blood Test May Revolutionize Brain Cancer Diagnosis

Scientists at Virginia Tech's Virginia Bioinformatics Institute working with the Center for Cancer and Blood Disorders at Children’s National Medical Center have found a new way to diagnose brain cancer based on genetic markers found in "junk DNA."

The finding, recently published in Oncotarget, could revolutionize the way doctors treat certain brain cancers, the second leading cancer-related cause of death in children.

According to the American Brain Tumor Association, 70,000 new patients were diagnosed with primary brain tumors in 2013, but only about a third turn out to be malignant. Ordinarily, when a patient shows symptoms of a brain tumor, an MRI is performed to locate tumors, but it cannot determine whether the tumor is benign or malignant, often necessitating costly and occasionally dangerous or inconclusive biopsies.

A simple blood test to detect genetic markers could change all that.

For complete article click here.


AlBioTech Teams with Leidos for Air Force Contract
AIBioTech®, a comprehensive contract research organization, is pleased to announce that it is acting as a subcontractor to Leidos, which was awarded a contract by the U.S. Air Force to provide research, development, testing and evaluation for Homeland Defense and Security Technical Area Tasks (HD TAT) to the Department of Defense (DoD) community of interest. Leidos is a national security, health and engineering solutions company and one of 12 contractors eligible to compete for task orders under the contract.

The contract has a total value of approximately $900 million if all options are exercised. The scope of work under the contract will encompass new and emerging adversary threats that could degrade U.S. (and allied) capabilities, new or extended capabilities in existing military systems and new technology applications to military problems.

For complete article click here.


New Offering for Virginia Bio Members
BIO BizLink is an online platform that connects biotech and pharma with a community of vendors to streamline pre-clinical and clinical R&D. BIO BizLink was developed for Virginia Bio members by the Biotechnology Industry Organization and Virginia Bio and powered by OnDeckBiotech!

Vendors maintain company profiles that include an overview of services, background documents, such as brochures and facility tours, introductions to key personnel (with LinkedIn profiles), and client testimonials. Each organization directly controls its own information and can provide real-time updates through an easy-to-use interface. Biotech and pharma tap into this community to quickly and easily identify qualified vendors for upcoming projects, execute confidential disclosure agreements (CDAs), distribute requests for proposals (RFPs) and process work orders.

For complete article click here.

Owens & Minor Implements Management Succession Plan
Owens & Minor, Inc. (NYSE:OMI), a healthcare logistics company headquartered in Richmond, has named President & Chief Operating Officer James L. Bierman, 61, to serve as President & Chief Executive Officer and appointed him as a director of the company, effective September 1, 2014. Craig R. Smith, 63, currently Chairman & Chief Executive Officer, will continue to serve the company in the role of Executive Chairman.

Bierman said, "I am honored to have the opportunity to lead Owens & Minor at such an exciting time in its history. I look forward to working with our first-rate executive team and the thousands of talented Owens & Minor teammates as we continue to execute our strategic plan and create sustainable value for customers and shareholders.”

For complete article click here.

Oxford Finance Closes $8 Million Senior Debt Facility with Natrix Separations
Oxford Finance LLC ("Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, announced the closing of an $8 million senior secured term loan agreement with Natrix Separations, Inc. ("Natrix”). Proceeds of the loan will be used for working capital.

"Oxford is pleased to provide financing to Natrix Separations, a company that utilizes a unique technology for manufacturing single use chromatography products,” said Christopher A. Herr, managing director for Oxford Finance. "The company, led by a talented management group, has been very successful with its product and is aggressively pursuing expansion opportunities into new markets.”

For complete article click here.

Welcome New Member: Data Blueprint

Data Blueprint is a data management consulting firm located in Glen Allen, VA that puts organizations on the right path to leverage data for competitive advantage and operational efficiency. It is their belief that strong data management capabilities are the key to sustained long-term value creation. Their approach leverages core competencies in both foundational and technical data management practices and they help clients leverage data as a strategic investment and become data-driven.

For more information please visit their website.

Welcome New Member: Finnegan

Finnegan, headquartered in Washington, DC, is one of the largest Intellectual Property law firms in the world. They offer full-service IP legal and technical experience in virtually every industry and technology—from electrical and computer technology, industrial manufacturing, consumer products, medical devices, and biotechnology to pharmaceuticals, chemicals, and alternative energy. The practice includes all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. They also represent clients on IP issues related to international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition.

For more information please visit their website.


Welcome New Member: Klick Health
Klick Health, established in 1997, is one of the world’s largest independent digital health agencies and is laser-focused on creating solutions that engage and educate healthcare providers about life-saving treatments. Klick helps inform and empower patients to manage their health and play a central role in their own care. Every solution hinges on Klick’s in-house expertise across the digital universe – strategy, creative, analytics, instructional design, user experience, relationship marketing, social and mobile.

For more information please visit their website.


Welcome New Member: Sensei Labs
As the latest innovation from Klick Health and the authors of The Decoded Company, Sensei Labs develops technologies to bring an organization’s belief system and enterprise operating system into alignment, creating teams that operate with flow, empathy, and situational awareness. Teams have high engagement and are self-managing. The company becomes agile and talent-centric, able to attract the brightest minds. Most importantly companies consistently out perform their competition by executing and evolving faster.

For more information please visit their website.


Welcome New Member: Thermo Fisher
Thermo Fisher Scientific Inc. serves science on a global scale, with revenues of $17 billion and 50,000 employees in 50 countries, including Middletown, VA. Their mission is to enable customers to make the world healthier, cleaner and safer. They help customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through their four brands – Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services – they offer a combination of innovative technologies, purchasing convenience and comprehensive support.

For more information please visit their website.
VABIO Community News TO TOP

Sherri Halloran, Virginia Bio’s Director of Membership Services has been selected as a member of the J&A Racing Ambassador Team for 2014-2015 racing season.

Tonya Mallory, President & CEO, Health Diagnostic Laboratory was recently named to Style Weekly’s Power List.

After 25 years of service, Charlotte Walker will be retiring from Wako Chemicals USA at the end of August. She started work at Wako the first day the building was opened in Chesterfield County.

PRA Health Sciences welcomes Paul Bunch, PhD, PMP as Executive Vice President and congratulates Emma Whieldon and Nicolle Leney on their recent promotions. Congratulations also to Lucy Morrow and her band The Madeline Rust on the release of another album and music video for the single Desert Rain.

HemoShear is asking for your vote in the Buzz of BIO contest. The competition recognizes some of the most innovative emerging biotechnology companies in the country. Vote here in the Late Stage Leader category. Voting ends August 29th at 5 pm ET.

BIO-CAT and BIO-CAT Microbials, recently unveiled their new responsive designed websites, www.bio-cat.com and www.bcmicrobials.com. The new innovative sites enhance the user’s experience with improved visual aesthetics, usability and functionality across all devices.

The recent newsletter mistakenly stated that Wako Chemicals was celebrating their 25th anniversary in the USA. The anniversary was actually their 25th in Richmond, VA. The USA office started in Dallas, TX in 1981.

VABIO Member Anniversaries TO TOP

Virginia Bio would like to thank our long term members who have recently celebrated their membership anniversaries:

VCU Life Sciences - 20 years

BOEHRINGER INGELHEIM - 19 YEARS
MERCK - 18 YEARS
COUNTY OF ROANOKE ECONOMIC DEVELOPMENT - 14 YEARS
ADVANCETEC - 10 YEARS

Virginia Bio would also like to thank our members renewing for the first time:

GLOBAL GENOMIC GROUP

VABIO Calendar TO TOP

sEPTEMBER 4
Event: Virginia Bio Public Policy Briefing
Where: Conference Call
When: Thursday, September 4, 9:30-10:30 AM
Details: Dial in to participate in this important conference call briefing from the comfort of your own office. We begin the new year cycle with high level briefings on important state and federal issues impacting all sectors of the Virginia bioscience industry including biotech, pharma, medical device, mobile and diagnostic. To see complete description click here.
Registration: Click here to register


SEPTEMBER 10
Event: VA Tobacco Commission Grant Program Info Session
Where: Mill Room, 1 Mill Road, Farmville
When: Wedneday, September 10, 10:00-11:00 AM or 1:00-2:00 PM
Details: More information


SEPTEMBER 11

Event: Virginia Bio Commercialization Luncheon
Where: Robert Ball Conference Center, Virginia Biotechnology Research Park
When: Thursday, September 11, 11:30 am - 1:30 pm, networking begins at 11:30, program begins at 12:00
Title: Focused Ultrasound Foundation
Details: The Focused Ultrasound Foundation in Charlottesville is an extraordinary, innovative and world class institution, devoted to improving the lives of millions of people worldwide with serious medical disorders by accelerating the development and adoption of focused ultrasound. Focused ultrasound is an early-stage, non-invasive therapeutic technology that could transform the treatment of many medical disorders by serving as an alternative to surgery and radiation. To see complete description click here.
Speakers: Chairman Dr. Neal Kassell and Scientific Director, Dr. Jessica Foley, Charlottesville
Registration: Register here. VCU students/faculty and VBRP tenants please contact Susan Moore for special instructions.
Sponsors: Data Blueprint, Greater Richmond Partnership, VCU Innovation Gateway and the Virginia Biotechnology Research Park

 


September 19-20
Event: LifeNet Health Cartilage Regeneration Symposium
Where: LifeNet Health, 1864 Concert Drive, Virginia Beach
Details: Click here for more information.

September 22
Event: VCU Sanger Series: Enhancing the Transparency and Reproducibility of Science
Where: VCU Sanger Hall, 1201 E. Marshall St., Richmond
Details: Click here for more information.


September 25
Event: MDMA 7th Annual Medical Technology Executive Forum
Where: Palo Alto, CA
Details: Click here for more information
Registration: Virginia Bio Members receive $100 off registration, contact Susan Moore for discount code


OCTOBER 6-8
Event: AdvaMed 2014
Where: McMormick Place, Chicago, Illinois
Details: Click here for more information
Registration: Virginia Bio Members receive a discount on registration, please contact Susan Moore for details.
Research Park

October 8
Event: Charlottesville Biotech and Beer
Where: U.Va. Licensing and Ventures, 250 W. Main Street, 3rd floor, Charlottesville
Details: Spice up your autumn evening with food, fun and lively conversation at Biotech and Beer. Meet old friends and new colleagues in the life science community. Complimentary admission for all bioscience company employees, and university students and researchers with advanced registration. All others may purchase tickets.
Registration: Click here
Sponsorships available, contact us for details.

OCTOBER 9
Event: Virginia Bio Commercialization Luncheon
Where: Robert Ball Conference Center, Virginia Biotechnology Research Park
When: Thursday, October 9, 11:30 am - 1:30 pm, networking begins at 11:30, program begins at 12:00
Title: Managing Risk at a Bioscience Company
Details: TBA
Registration: Coming soon
Sponsors: Data Blueprint, Greater Richmond Partnership, VCU Innovation Gateway and the Virginia Biotechnology Research Park


OCTOBER 12-16
Event: Focused Ultrasound 2014 4th International Symposium
Where: Bethesda North Marriott and Conference Center, Bethesda, MD
Details: More information


OCTOBER 21
Event: VCU Sanger Series: Science and the World's Future
Where: VCU Sanger Hall, 1201 E. Marshall St., Richmond
Details: More information


OCTOBER 24
Event: 2nd Pediatric Surgical Innovation Symposium
Where: The Knight Conference Center at the Newseum, Washington, DC
When: Friday, October 24, 8:00 am - 5:00 pm
Details:
More information

ABOUT VIRGINIA BIO
Virginia Bio, was formed in 1992 and incorporated in the Commonwealth of Virginia as a non-profit association. The purpose of the Association is to promote the biotechnology industry in Virginia, expand the knowledge and expertise of Virginia's businesses concerning biotechnology through seminars, educational publications and other means, to enhance public awareness of the biotechnology industry in Virginia and the scientific, economic and other benefits it provides, and to represent the interests of the biotechnology industry in Virginia before federal, state and local legislators and regulators. We provide a forum for members and their guests to get to know each other and the many bioscience companies operating today in Virginia and serving our biotech community. We coordinate information among the many agencies and organizations interested in biotechnology.

To learn more about Virginia Bio and how you can get involved, Click Here


This is the E-newsletter of Virginia Bio, a non-profit organization dedicated to supporting the Life Sciences community in the Commonwealth of Virginia. New subscribers can join at our website, www.vabio.org.
@@unsubscribe_url@
This email was sent to '@@email@@' from Virginia Bio. If you wish to stop receiving email from us, you can simply remove yourself by clicking here.
In order to continue receiving emails from Virginia Bio, please add VABIOConnections@vabio.org to your safe sender list.
This email was sent to '@@email@@' from Virginia Bio. If you wish to stop receiving email from us, you can simply remove yourself by clicking here.
In order to continue receiving emails from Virginia Bio, please add VABIOConnections@vabio.org to your safe sender list.
more Events

12/8/2016
Virginia Bioscience Commercialization Luncheon- December 2016

12/12/2016 » 12/14/2016
ISBioTech 4th Fall Meeting

Premium Members

Membership Software Powered by YourMembership  ::  Legal